The relationship of the apolipoprotein e gene polymorphism in Turkish Type 2 diabetic patients with and without nephropathy

Journal of Endocrinological Investigation

Volumn 32, Issue 3, 2009, Pages 219-222

  Erdogan, M ^a   Eroglu, Z ^a   Biray, C ^a   Karadeniz, M ^a   Cetinkalp, S ^a   Kosova, B ^a   Gunduz, C ^a   Topcuoglu, N ^a   Ozgen, G ^a   Yilmaz, C ^a  

^a EGE UNIVERSITY SCHOOL OF MEDICINE   (Turkey)

Author keywords

Apoe gene polymorphism; Diabetic nephropathy; Turkish population

Indexed keywords

APOLIPOPROTEIN E; GENOMIC DNA;

ADULT; AGED; ARTICLE; CHRONIC KIDNEY DISEASE; CONTROLLED STUDY; DIABETIC NEPHROPATHY; DIAGNOSTIC KIT; DNA POLYMORPHISM; ETHNIC DIFFERENCE; FEMALE; GENE FREQUENCY; GENETIC VARIABILITY; HUMAN; KIDNEY DISEASE; LEUKOCYTE; LIPOPROTEIN BLOOD LEVEL; MAJOR CLINICAL STUDY; MALE; NON INSULIN DEPENDENT DIABETES MELLITUS; TURKEY (REPUBLIC);

EID: 67651242245     PISSN: 03914097     EISSN: None     Source Type: Journal    
DOI: 10.1007/BF03346455     Document Type: Article

References (21)

1. Baum L, Ng MC, So WY, et al. Effect of hepatic lipase -514C->T polymorphism and its interactions with apolipoprotein C3-482C->T and apolipoprotein E exon 4 polymorphisms on the risk of nephropathy in Chinese type 2 diabetic patients. Diabetes Care 2005, 28: 1704-1709
2. Mahley RW, Innerarity TL, Rall SC Jr, Weisgraber KH. Plasma lipoproteins: apolipoprotein structure and function. J Lipid Res 1984, 25: 1277-1294 (Pubitemid 15150638)
3. Utermann G. Apolipoprotein E polymorphism in health and disease. Am Heart J 1987, 113: 433-440 (Pubitemid 17026619)
4. Liberopoulos E, Siamopoulos K, Elisaf M. Apolipoprotein E and renal disease. Am J Kidney Dis 2004, 43: 223-233
5. Vauhkonen I, Niskanen L, Ryynënen M, et al. Divergent association of apolipoprotein E polymorphism with vascular disease in patients with NIDDM and control subjects. Diabet Med 1997, 14: 748-756 (Pubitemid 27390855)
6. Reilly SL, Ferrell RE, Sing CF. The gender-specific apolipoprotein E genotype influence on the distribution of plasma lipids and apolipoproteins in the population of Rochester, MN. III. Correlations and covariances. Am J Hum Genet 1994, 55: 1001-1018 (Pubitemid 24334294)
7. Xhignesse M, Lussier-Cacan S, Sing CF, Kessling AM, Davignon J. Influences of common variants of apolipoprotein E on measures of lipid metabolism in a sample selected for health. Arterioscler Thromb 1991, 11: 1100-1110
8. Bickeböller H, Campion D, Brice A, et al. Apolipoprotein E and Alzheimer disease: genotype-specific risks by age and sex. Am J Hum Genet 1997, 60: 439-446 (Pubitemid 27058416)
9. Bonnet F, Cooper ME. Potential influence of lipids in diabetic nephropathy: insights from experimental data and clinical studies. Diabetes Metab 2000, 26: 254-264 (Pubitemid 30740076)
10. Chowdhury TA, Dyer PH, Kumar S, Barnett AH, Bain SC. Genetic determinants of diabetic nephropathy. Clin Sci (Lond) 1999, 96: 221-230
11. Kimura H, Suzuki Y, Gejyo F, et al. Apolipoprotein E4 reduces risk of diabetic nephropathy in patients with NIDDM. Am J Kidney Dis 1998, 31: 666-673 (Pubitemid 28158008)
12. Leiva E, Mujica V, Orrego R, Prieto M, Arredondo M. Apolipoprotein E polymorphism in type 2 diabetic patients of Talca, Chile. Diabetes Res Clin Pract 2005, 68: 244-249 (Pubitemid 40775992)
13. Onuma T, Laffel LM, Angelico MC, Krolewski AS. Apolipoprotein E genotypes and risk of diabetic nephropathy. J Am Soc Nephrol 1996, 7: 1075-1078 (Pubitemid 27465972)
14. Werle E, Fiehn W, Hasslacher C. Apolipoprotein E polymorphism and renal function in German type 1 and type 2 diabetic patients. Diabetes Care 1998, 21: 994-998 (Pubitemid 28488794)
15. Hsieh MC, Lin SR, Yang YC, Chen HC, Lin JN, Shin SJ. Higher frequency of apolipoprotein E2 allele in type 2 diabetic patients with nephropathy in Taiwan. J Nephrol 2002, 15: 368-373
16. Ilhan N, Kahraman N, Seckin D, Ilhan N, Colak R. Apo E gene polymorphism on development of diabetic nephropathy. Cell Biochem Funct 2006, 25: 527-532
17. Pettitt DJ, Saad MF, Bennett PH, et al. Familial predisposition to renal disease in two generations of Pima Indians with type 2 (non-insulin-dependent) diabetes mellitus. Diabetologia 1990, 33: 438-443 (Pubitemid 20220945)
18. Freedman BI, Tuttle AB, Spray BJ. Familial predisposition to nephropathy in African-Americans with non-insulin-dependent diabetes mellitus. Am J Kidney Dis 1995, 25: 710-713
19. Eto M, Saito M, Okada M, et al. Apolipoprotein E genetic polymorphism, remnant lipoproteins, and nephropathy in type 2 diabetic patients. Am J Kidney Dis 2002, 40: 243-251 (Pubitemid 34827641)
20. Chowdhury TA, Dyer PH, Kumar S, et al. Association of apolipoprotein epsilon2 allele with diabetic nephropathy in Caucasian subjects with IDDM. Diabetes 1998, 47: 278-280 (Pubitemid 28079987)
21. Araki S, Moczulski DK, Hanna L, Scott LJ, Warram JH, Krolewski AS. APOE polymorphisms and the development of diabetic nephropathy in type 1 diabetes: results of case-control and family-based studies. Diabetes 2000, 49: 2190-2195